NICE

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

[NICE @NICEComms]

The Childhood Tumour Trust has welcomed NICE's recommendation of mirdametinib as a new treatment option for children and young people with these rare tumours.

[NICE @NICEComms]

A new treatment option could benefit around 200 children and young people with rare nerve tumours.

NICE has recommended mirdametinib in final draft guidance, offering another option for some families when surgery isn't possible.

Find out more ⬇️
https://t.co/oV7AW5p7Ld

[NICE @NICEComms]

Find out about our priorities and work in health and social care at this month’s public board meeting.

Register here: https://t.co/5wxhDYQ1WV

[NICE @NICEComms]

"No one can understand the process as well as a patient."

Debra survived a heart attack at 38 and joined a NICE committee as a lay member to help shape our digital cardiac rehabilitation guidance.

Patient perspective is at the heart of everything we do: https://t.co/Af5oqCnWw7

[NICE @NICEComms]

We've published our EQ-5D-5L interim methods statement, ahead of a full modular update later this year.

The statement sets out key elements of the updated methods and implementation approach to support transition to the new value set.

Learn more: https://t.co/iTwU2w420T

[NICE @NICEComms]

Children and young people aged 5 to 17 with severe allergies caused by tree pollen could benefit from a targeted daily treatment after NICE published final guidance recommending betula verrucosa (Itulazax 12 SQ-Bet)

Find out more ⬇️
https://t.co/wMODjACWzO

[NICE @NICEComms]

More children with severe allergies caused by house dust mites could benefit from a targeted daily treatment after NICE published final guidance recommending 12 SQ-HDM SLIT for children aged 5 to 11.

Find out more⬇️
https://t.co/sakrR8ryLz

[NICE @NICEComms]

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel.

📱On mobile? Join here: https://t.co/xxeOwkx9RB

🖥️On desktop? Scan the QR code in the video.

🔔Once subscribed hit the bell to stay notified.

[Department of Health and Social Care @DHSCgovuk]

From today, @NHSEngland is inviting women who have fallen behind on their cervical screening to order a HPV self-testing kit.

The free kits can be used at home, making it easier for more women to complete potentially lifesaving checks to help prevent cervical cancer.

https://t.co/nAQI1Uxa04

[NHS England @NHSEngland]

Millions of women in England are to be offered HPV self-testing kits, with the service rolling out today.

Those who haven’t attended cervical screening following previous invitations will be offered a kit as an alternative way to take part.

➡️ https://t.co/XKVLe6DiQQ

[NICE @NICEComms]

Hundreds of thousands of people with type 2 diabetes could benefit from a new weekly insulin injection after NICE recommended insulin efsitora alfa.

The treatment could reduce injections from 365 a year to just 52.

Find out more 👇
https://t.co/b4EZXLlYDD

[NICE @NICEComms]

As AI becomes more common across health and care, public trust matters.

That's why AI is the focus of our next NICE Listens dialogue, exploring the values and principles people want to see shape its use: https://t.co/jVq4ledTmM

[NICE @NICEComms]

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel.

📱On mobile? Join here: https://t.co/xxeOwkx9RB

🖥️On desktop? Scan the QR code in the video.

🔔Once subscribed hit the bell to stay notified.

[NICE @NICEComms]

Many living with PMOS wait years for diagnosis and support.

In our latest #NICETalks podcast, Professor Aled Rees and Sharon Manship discuss:

▪️NICE's new guideline
▪️the move from PCOS to PMOS
▪️how annual reviews could improve care

https://t.co/ghTxPWgM0l

[NICE @NICEComms]

Modern Service Frameworks aim to improve access to high-quality care nationally.

With the first frameworks for cardiovascular disease and sepsis now published, and 4 more to follow, find out how NICE is helping put evidence at the heart of this work.
🔗https://t.co/5Zg6FvhfTF

[NICE @NICEComms]

Children aged five and over are set to benefit after we recommended widening access to targeted treatments for severe dust mite and birch tree pollen allergies today. Find out more about 12 SQ-HDM SLIT and betula verrucosa:

https://t.co/X79RWtyPT8

[NICE @NICEComms]

Transform your AI and digital healthtech evidence strategy with experts from NICE Advice.

Learn how to:

- build compelling evidence
- create strong value propositions
- navigate NICE guidance selection.

Book now: https://t.co/0ByQNAKgdv

[NICE @NICEComms]

Help shape how NICE evaluates treatments for MASH.

We're consulting on proposed changes to the methods used to assess treatments for liver fibrosis related to metabolic dysfunction-associated steatohepatitis (MASH).

📅 Respond by 9 September.
https://t.co/gXMcr8t5Qf

[NICE @NICEComms]

Modern Service Frameworks aim to improve access to high-quality care nationally.

With the first frameworks for cardiovascular disease and sepsis now published, and 4 more to follow, find out how NICE is helping put evidence at the heart of this work.
🔗https://t.co/DQ2ASjH2B9

[NICE @NICEComms]

AI is already beginning to change healthcare.

Our new plan outlines how NICE will support the safe, effective and scalable adoption of AI in the NHS: https://t.co/eyW6Y7qNQD